Le Lézard
Classified in: Health, Science and technology
Subject: PLW

Strathspey Crown LLC Announces Issuance of US Patent of the First Implantable Intraocular Lens (IOL) with a Video Camera and Wireless Transmission Capability


NEWPORT BEACH, Calif., July 12, 2017 /PRNewswire/ -- Strathspey Crown LLC, a lifestyle healthcare company focused in ophthalmology, medical aesthetic and elective technologies and procedures, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 9,662,199 covering an implantable intraocular lens with an optic (including accommodating, multifocal and phakic configurations), a camera and an LED display, and a communications module that wirelessly transmit and receive information from an external device (e.g. PDA).  

Strathspey Crown LLC (PRNewsfoto/Strathspey Crown LLC)

Robert Edward Grant, Founder and Chairman of Strathspey Crown LLC commented, "Video cameras are now a standard feature of smart phone technology and wearable cameras have become popularized by companies like Google and Snap in recent years.  This patent represents a significant step forward in the rapidly growing sector of human cyborg technology.  The eye, as a transparent medium for light, is ideal for advanced and rechargeable implantables that enable video capture of all of life's experiences.  Our broader vision is to develop ground-breaking medical-grade ocular smart implantables that integrate cellular, WIFI and 802.11 transmissions in an elegant cognitive interface that we believe will enhance human intelligence, augment perceived reality, and digitally capture experiences and individual memories.  We look forward to several continuations and expansions on this important intellectual property portfolio."

Grant further commented, "Although Samsung, Sony and Google have all recently filed patent applications related to the same field, Strathspey Crown is thus far the only company to hold an issued patent in this promising ocular smart implant category. Our first camera-integrated acrylic IOLs will be completed in 2018, upon which we plan to pursue an FDA Investigational Device Exemption (IDE) and subsequent Pre-Market Approval (PMA) and related clinical trial."

About Strathspey Crown LLC:
Strathspey Crown is a growth equity firm specializing in lifestyle healthcare. The firm's subsidiaries and investors include board certified physician specialists across key medical specialties, including plastic surgery, ophthalmology, dermatology, dentistry and orthopedics. Strathspey Crown is focused on working with physician investors to bring to market innovative technologies and services in the self-pay sector of the lifestyle healthcare market. For more information, please visit www.strathspeycrown.com.

STRATHSPEY CROWN LLC Press Contact: 
Diana Fraser, Director 
Tel: +1 949.260.1700
Email: [email protected]

 

SOURCE Strathspey Crown LLC


These press releases may also interest you

at 11:34
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the...

at 11:25
TimelyCare, higher education's most trusted virtual health and well-being provider, has earned recognition as one of the World's Best Digital Health Companies by Newsweek, and has been awarded five Top Workplaces Awards for culture excellence....

at 11:16
Avanos Medical, Inc. will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market...

at 11:15
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision oncology therapeutics, announced the approval to expand the use of vebreltinib (also referred...

at 11:10
Through its 2030 Strategic Plan, NJII plans to double the size of the organization and to exceed $70M revenue as it rolls out various new initiatives focused on accelerating technology translation, spurring innovation and upskilling workers. As...

at 11:09
ScreenPoint Medical, today announced a significant transition in its leadership as Mark Koeniguer, the current CEO, steps down from his position. Mark served as CEO since 2022 and was instrumental in ScreenPoint's commercial growth and success over...



News published on and distributed by: